MA
PCRX icon

MCF Advisors’s Pacira BioSciences PCRX Stock Holding History

MCF Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50
Closed -$1.43K – 1049
2024
Q2 		$1.43K Hold
50
– – ﹤0.01% 874
2024
Q1 		$1.46K Hold
50
– – ﹤0.01% 846
2023
Q4 		$1.69K Buy
+50
New +$1.46K ﹤0.01% 796
2017
Q1 		– Sell
-200
Closed -$6K – 477
2016
Q4 		$6K Hold
200
– – ﹤0.01% 358
2016
Q3 		$7K Hold
200
– – ﹤0.01% 355
2016
Q2 		$7K Hold
200
– – ﹤0.01% 380
2016
Q1 		$11K Hold
200
– – ﹤0.01% 318
2015
Q4 		$15K Buy
+200
New +$11.3K ﹤0.01% 292

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

MCF Advisors's PCRX Position: Q3 2024 in Review

MCF Advisors sold out of Pacira BioSciences (PCRX) in Q3 2024, closing a stake of 50 shares — an estimated $1.43K sold.

MCF Advisors first reported a position in PCRX in Q4 2015 and held it in 8 quarters. The position peaked at $15K in Q4 2015. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.

  • MCF Advisors reported no remaining Pacira BioSciences position as of Q3 2024 after selling out during the quarter.
  • MCF Advisors sold 50 Pacira BioSciences shares in Q3 2024, an estimated $1.43K.
  • MCF Advisors first reported a position in Pacira BioSciences in Q4 2015 and held it in 8 quarters.
  • MCF Advisors's Pacira BioSciences position peaked at $15K in Q4 2015.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.

Based on MCF Advisors's 13F filing for Q3 2024, filed 24 Oct 2024.